Abstract | BACKGROUND: METHODS: From the eight studies that met our selection criteria, two efficacy and six safety parameters were selected for calculation of number needed to treat (NNT), number needed to harm (NNH), and the likelihood of being helped or harmed (LHH) using comparisons of active drug relative to placebo. NNTs for prevention of relapse ranged from 2 to 5 for paliperidone palmitate, haloperidol decanoate, and fluphenazine decanoate, indicating a moderate to large effect size. RESULTS: CONCLUSION:
|
Authors | Srihari Gopal, Joris Berwaerts, Isaac Nuamah, Kasem Akhras, Danielle Coppola, Ella Daly, David Hough, Joseph Palumbo |
Journal | Neuropsychiatric disease and treatment
(Neuropsychiatr Dis Treat)
Vol. 7
Pg. 93-101
( 2011)
ISSN: 1178-2021 [Electronic] New Zealand |
PMID | 21552311
(Publication Type: Journal Article)
|